Skip to main content

Maxcyte, Inc.

MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001287098

No open-market purchases or sales by Maxcyte, Inc. insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $78.0M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Maxcyte, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of MXCT: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders115116+1
Shares66.6M66.1M−527.5K (−0.8%)
Value$327.9M$303.3M−$24.6M (−7.5%)

New holders (12)

Institutions that held Maxcyte, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to MXCT in Q2 2023
InstitutionSharesValue% of portfolio
Alberta Investment Management Corp176,812$811.6K0.01%
Alyeska Investment Group, L.P.166,630$764.8K0.01%
Chevy Chase Trust Holdings, Inc.47,381$217.5K0.00%
Franklin Resources Inc42,928$197.0K0.00%
State Board of Administration of Florida Retirement System24,810$113.6K0.00%
Two Sigma Investments, LP15,661$71.9K0.00%
Fox Run Management, L.L.C.13,510$62.0K0.02%
Cerity Partners LLC12,510$57.7K0.00%
Harbor Capital Advisors, Inc.5,652$25.9K0.01%
Simplex Trading, LLC515$2.00K0.00%
Signaturefd, LLC201$9230.00%
Quadrant Capital Group LLC81$3720.00%

Sold out (11)

Institutions that held Maxcyte, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of MXCT in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Bamco Inc1,987,904$9.84M
AWM Investment Company, Inc.500,000$2.48M
Baillie Gifford & Co293,325$1.41M
J. Goldman & Co LP175,000$866.3K
Tamarack Advisers, LP100,000$495.0K
DekaBank Deutsche Girozentrale38,500$179.0K
SG Americas Securities, LLC35,516$176.0K
Russell Investments Group, Ltd.33,155$164.1K
HRT Financial LP16,883$83.0K
Cubist Systematic Strategies, LLC12,750$63.1K
Bank of Montreal3,974–